Safety, activity, and molecular heterogeneity following neoadjuvant non-pegylated liposomal doxorubicin, paclitaxel, trastuzumab, and pertuzumab in HER2-positive breast cancer (Opti-HER HEART): an…

Overview of attention for article published in BMC Medicine, January 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

twitter: 37 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 28 Dimensions

Readers on

mendeley: 74 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 2 public wall posts from 1 users.

BVMS: Biblioteca Virtual Murciasalud, 09 Jul 2019

#PubsaludMurcia Safety, activity, and molecular heterogeneity following neoadjuvant non-pegylated liposomal doxorubicin…

BVMS: Biblioteca Virtual Murciasalud, 11 Jan 2019

#PubSaludMurcia Safety, activity, and molecular heterogeneity following neoadjuvant non-pegylated liposomal doxorubicin…

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.